immatics biotechnologies GmbH
Biotechnology
-
Short facts
-
- Manufacturer
- Year founded not available
- Employees (site): not available
- Turnover: not available
Products/services: immatics has a good track record of success: We are optimistic that we have found a way to develop drugs against cancer that might one day help many cancer patients. The product candidates are designed to have less severe side effects than currently available treatment options. immatics has developed peptide-based active immunotherapy with unprecedented speed and efficiency, setting new standards for discovery and development in this area of oncology drug development. Our technology can also lead towards the development of novel immunotherapies based on antibodies and T-cell receptors. We are currently working on the development of new substances for a number of specific cancer types. Our most advanced product is currently being developed in a phase 3 clinical trial for kidney cancer. immatics has a good track record of success: We are optimistic that we have found a way to develop drugs against cancer that might one day help many cancer patients. The product candidates are designed to have less severe side effects than currently available treatment options. immatics has developed peptide-based active immunotherapy with unprecedented speed and efficiency, setting new standards for discovery and development in this area of oncology drug development. Our technology can also lead towards the development of novel immunotherapies based on antibodies and T-cell receptors. We are currently working on the development of… read more
Basic data
Company
immatics biotechnologies GmbH
Street
Machtfliegerstr. 11
PC / City
81379 München
County
Upper Bavaria
Phone
+49 89 540415-0
Fax
+49 89 540415-905
Homepage
Language skills
English
Profile/competences
Core competencies
not available
Key sectors / sub-sectors
- Biotechnology: Therapeutic drug development
Certifications
not available
Sales markets - target industries
not available
Sales markets - target countries
not available
Cooperation offers
not available